Abstract
The understanding of fundamental phenomena involved in tissue engineering and regenerative medicine is continuously growing and leads to the demand for three-dimensional (3D) models that better represent tissue architecture and direct cells into the proper lineage for specific tissue repair. Porous 3D scaffolds are used in tissue engineering as templates to allow cell attachment and tissue formation. Scaffold design plays a central role in guiding cells to synthesize and maintain new tissues. While a number of techniques have been developed and are now in use for high-throughput screening of combinatorial factors involved in biotechnology in two-dimensions, high-throughput screening in 3D is still in its infancy. There is a broad interest in developing similar techniques to assess which variables are critical in designing 3D scaffolds to achieve proper and lasting tissue regeneration. We describe, herein, a number of studies adopting smart scaffold design and in vitro and in vivo analysis as the basis for 3D model systems for evaluating combinatorial factors influencing cell differentiation and tissue formation.
Combinatorial Chemistry & High Throughput Screening
Title: Combinatorial Approaches to Controlling Cell Behaviour and Tissue Formation in 3D via Rapid-Prototyping and Smart Scaffold Design
Volume: 12 Issue: 6
Author(s): Tim B.F. Woodfield, Lorenzo Moroni and Jos Malda
Affiliation:
Abstract: The understanding of fundamental phenomena involved in tissue engineering and regenerative medicine is continuously growing and leads to the demand for three-dimensional (3D) models that better represent tissue architecture and direct cells into the proper lineage for specific tissue repair. Porous 3D scaffolds are used in tissue engineering as templates to allow cell attachment and tissue formation. Scaffold design plays a central role in guiding cells to synthesize and maintain new tissues. While a number of techniques have been developed and are now in use for high-throughput screening of combinatorial factors involved in biotechnology in two-dimensions, high-throughput screening in 3D is still in its infancy. There is a broad interest in developing similar techniques to assess which variables are critical in designing 3D scaffolds to achieve proper and lasting tissue regeneration. We describe, herein, a number of studies adopting smart scaffold design and in vitro and in vivo analysis as the basis for 3D model systems for evaluating combinatorial factors influencing cell differentiation and tissue formation.
Export Options
About this article
Cite this article as:
Woodfield B.F. Tim, Moroni Lorenzo and Malda Jos, Combinatorial Approaches to Controlling Cell Behaviour and Tissue Formation in 3D via Rapid-Prototyping and Smart Scaffold Design, Combinatorial Chemistry & High Throughput Screening 2009; 12 (6) . https://dx.doi.org/10.2174/138620709788681899
DOI https://dx.doi.org/10.2174/138620709788681899 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases)
Current Pharmaceutical Design Overview: Antioxidants: A “Higgs Boson” in Animal Health and Production
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Preface: MicroRNA: A Newcomer to Biological Science
MicroRNA Inhalational Anesthetics in Acute Severe Asthma
Current Drug Targets Impact of Red Wine Consumption on Cardiovascular Health
Current Medicinal Chemistry Metabolic Features Across the Female Life Span in Women with PCOS
Current Pharmaceutical Design Pathophysiology of Post-Operative Low Cardiac Output Syndrome
Current Vascular Pharmacology Editorial [Hot Topic: Exploring the Links between Obesity and Alzheimers Disease (Guest Editor: Suzana S. Petanceska) ]
Current Alzheimer Research Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
Current Aging Science Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Current Neuropharmacology Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patient with Hodgkin's Lymphoma History from North of Iran
Infectious Disorders - Drug Targets Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis
Anti-Cancer Agents in Medicinal Chemistry Breast Cancer: Biological Characteristics in Postmenopausal Type 2 Diabetic Women. Identification of Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Possible Use of Terpene Compounds in DC Immunotherapy against Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases
Current Pharmaceutical Design LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Current Pharmaceutical Design Therapeutic Applications of Human Heme Oxygenase Gene Transfer and Gene Therapy
Current Pharmaceutical Design Towards Prevention of Ovarian Cancer
Current Cancer Drug Targets Treatment of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Gene Therapy in the Transplantation of Allogeneic Organs and Stem Cells
Current Gene Therapy